Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 85

Sort by

Sort Order Select

Journal Articles

Combination of the MEK Inhibitor Trametinib and Pyrvinium Pamoate Efficiently Targets RAS Pathway-Mutated Acute Myeloid Leukemia in Preclinical Models

Blood (2019) 134 (Supplement_1): 2671.

https://doi.org/10.1182/blood-2019-123418

Published: 2019

Journal Articles

Results from a Phase 2 Study of Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary Myelofibrosis

Claire N Harrison, Professor, Jacqueline S Garcia, MD, Ruben A Mesa, MD, Tim CP Somervaille, MD PhD, Rami S. Komrokji, MD, Naveen Pemmaraju, MD, Catriona Jamieson, MD PhD, Nikolaos Papadantonakis, MDPhDMSc, James M. Foran, MD, Casey L. O'Connell, MD, Leanne Holes, BS, MBA,, Jia Jia, PhD MBA, Jason Harb, PhD, Jessica Hutti, PhD, Josef T. Prchal, MD

Blood (2019) 134 (Supplement_1): 671.

https://doi.org/10.1182/blood-2019-130158

Published: 2019

Journal Articles

Impact of FLT3 -ITD Remission Depth in Acute Myeloid Leukemia Patients Prognosis Prediction before Allogeneic Hematopoietic Cell Transplantation

Xiaoyu Xu, Hongjie Shen, Jia Chen, Xiaowen Tang, Shengli Xue, Xu Yang, Qiaocheng Qiu, Zixuan Ding, Suning Chen, Depei Wu, MD PhD

Blood (2019) 134 (Supplement_1): 262.

https://doi.org/10.1182/blood-2019-130381

Published: 2019

Journal Articles

Incidence of Differentiation Syndrome with Ivosidenib (IVO) and Enasidenib (ENA) for Treatment of Patients with Relapsed or Refractory (R/R) Isocitrate Dehydrogenase (IDH)1- or IDH2-Mutated Acute Myeloid Leukemia (AML): A Systematic Analysis By the U.S. Food and Drug Administration (FDA)

Kelly J. Norsworthy, MD, Flora Mulkey, MS, Ashley F. Ward, MD, Donna Przepiorka, MDPhD, Albert B. Deisseroth, MD PhD, Ann T. Farrell, MD, Richard Pazdur, MD

Blood (2018) 132 (Supplement 1): 288.

https://doi.org/10.1182/blood-2018-99-117426

Published: 2018

Journal Articles

Increased Monocytic Myeloid-Derived Suppressor Cells in the Marrow of Relapsed/Refractory Acute Myeloid Leukemia Patients Following Induction Chemotherapy

Amanda Przespolewski, DO, Paul K. Wallace, MS, PhD, Tara Cronin, BA, Eunice S. Wang, MD

Blood (2018) 132 (Supplement 1): 5270.

https://doi.org/10.1182/blood-2018-99-120082

Published: 2018

Journal Articles

Atypical Chronic Myeloid Leukemia

Chandralekha Ashangari, MD, Praveen K. Tumula, MD

Blood (2018) 132 (Supplement 1): 5455.

https://doi.org/10.1182/blood-2018-99-110189

Published: 2018

Journal Articles

Clinical Benefit of Ropeginterferon Alfa 2b (P1101) in Patients with Myelofibrosis

Jeanne Palmer, MD, Heidi E. Kosiorek, MS, Craig Zimmerman, PhD, Oleh Zagrijtschuk, MD, John Camoriano, MD, Ruben A. Mesa, MD

Blood (2018) 132 (Supplement 1): 5475.

https://doi.org/10.1182/blood-2018-99-115521

Published: 2018

Journal Articles

Increased Disease Burden Among Black Children Compared to White Children with Newly Diagnosed Acute Myeloid Leukemia

Lena E. Winestone, MD MSHP, Kelly D Getz, PhD, Yimei Li, PhD, Evanette Burrows, MPH, Michael Scheurer, MPH, PhD, M. Monica Gramatges, MD PhD, Jennifer J. Wilkes, MD, Tamara P. Miller, MDMSc, Alix E. Seif, MD, Robert W. Grundmeier, MD, Karen R. Rabin, MD PhD, Brian T. Fisher, DO, Richard Aplenc, MD PhD

Blood (2018) 132 (Supplement 1): 369.

https://doi.org/10.1182/blood-2018-99-120076

Published: 2018

Journal Articles

Targeting of the Interleukin-7 Receptor Alpha-Chain (IL-7Rα) Blocks B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Development and Reduces Leukemic Infiltration to the Central Nervous System (CNS)

Ameera Alsadeq, PhD, Anila George Vadakumchery, Ali Almasri, Hend Abdelrasoul, Markus Werner, PhD, Lennart Lenk, Felix Seyfried, Klaus-Michael Debatin, MD, Lueder-Hinrich Myer, MD, Gunnar Cario, MD, Martin Schrappe, MD PhD, Denis Martin Schewe, MD, Hassan Jumaa, PhD

Blood (2017) 130 (Supplement 1): 479.

https://doi.org/10.1182/blood.V130.Suppl_1.479.479

Published: 2017

Journal Articles

Complex Karyotype Predicts the Prognostics Impact of WBC Count in Untreated Mantle Cell Lymphoma and Is Associated with Shortened Survival Independent of Specific Cytogenetic Abnormalities

Irl Brian Greenwell, MD, Jeffrey M. Switchenko, PhD MS, Ashley D. Staton, MD, Debra Saxe, PhD, Joseph Maly, MD, Kristie A. Blum, MD, Natalie Grover, MD, Stephanie Mathews, Steven I Park, MD, Max J Gordon, MD, Alexey Danilov, MD PhD, Narendranath Epperla, MD, Timothy S. Fenske, MD, Mehdi Hamadani, MD, Christopher Flowers, MD, Jonathon B Cohen, MDMS

Blood (2017) 130 (Supplement 1): 1499.

https://doi.org/10.1182/blood.V130.Suppl_1.1499.1499

Published: 2017

Journal Articles

Examining the Treatment Patterns and Blood Counts Among Patients with Polycythemia Vera Treated with Hydroxyurea in the United States: An Analysis from the Reveal Study

Michael Richard Grunwald, MD, Ivy Altomare, MD, John M. Burke, MD, Aaron T. Gerds, MDMS, Mark A. Walshauser, MD, Michael R. Savona, MD, David J Kuter, MD DPhil, Brady Lee Stein, MD MHS, Stephen Oh, MD PhD, Philomena Colucci, DO, MS, Ahmad B. Naim, MD, Dilan Chamikara Paranagama, PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 1633.

https://doi.org/10.1182/blood.V130.Suppl_1.1633.1633

Published: 2017

Journal Articles

JAK2 V617F -Mutant Vascular Niche Promotes JAK2 V617F Clonal Expansion in Myeloproliferative Neoplasms

Huichun Zhan, MD, Chi Hua Sarah Lin, PhD, Yarden Segal, Kenneth Kaushansky, MD

Blood (2016) 128 (22): 952.

https://doi.org/10.1182/blood.V128.22.952.952

Published: 2016

Journal Articles

Nuclear NFATc1 Causes Development of Fms-like Receptor Tyrosine Kinase 3 Receptor (FLT3) Internal Tandem Duplication Mutation-Positive (FLT3-ITD) Acute Myeloid Leukemia (AML) and Mediates Drug Resistance

Maria A. Solovey, Ying Wang, MD, Stefan Gattenloehner, MD, Elisabeth Hessmann, MD, Stephan Metzelder, MD, Christian Michel, MD, Volker Ellenrieder, MD, Joachim R. Goethert, MD, Andreas Neubauer, Andreas Burchert, MD

Blood (2016) 128 (22): 1722.

https://doi.org/10.1182/blood.V128.22.1722.1722

Published: 2016

Journal Articles

Engraftment and Long-Term Survival at Low Burden of Leukemic Blasts from Primary MRD+ Human Bone Marrow in a Xenotransplant Setting

Nina Rolf, MD PhD, Angela Tsang, BSc, RT, Abbas Fotovati, DVM, PhD, Arnawaz Bashir, PhD, Patrice Eydoux, MD, Suzanne M Vercauteren, MD PhD, Gregor SD Reid, PhD

Blood (2016) 128 (22): 1730.

https://doi.org/10.1182/blood.V128.22.1730.1730

Published: 2016

Journal Articles

Mathematical Modeling of White Blood Cell Population Dynamics for Diagnosis and Prognosis

Anwesha Chaudhury, PhD, Aliyah R Sohani, MD, John M. Higgins, MD

Blood (2016) 128 (22): 1333.

https://doi.org/10.1182/blood.V128.22.1333.1333

Published: 2016

Journal Articles

Venous Thromboembolic Events in Diffuse Large B Cell Lymphoma Patients: Risk Factors and Outcomes

Sabarish Ram Ayyappan, MBBS, Vinita Gupta, MD, Akiva Diamond, MD, Brenda Cooper, MD, Ben K. Tomlinson, MD, Ehsan Malek, MD, Leland Metheny, MD, Hillard M. Lazarus, MD, Stanton L. Gerson, MD, Marcos De Lima, MD, Paolo F. Caimi, MD

Blood (2016) 128 (22): 3611.

https://doi.org/10.1182/blood.V128.22.3611.3611

Published: 2016

Journal Articles

Immature Platelet Fraction Is Associated with JAK2 V617F Mutation and Features of Advanced Disease in Myelofibrosis

Paolo Strati, MD, Pritviraj Bose, Katie Gaw, Lingsha Zhou, Sherry Pierce, BSN, BA, Julie Huynh-Lu, Carlos E. Bueso-Ramos, MD PhD, Srdan Verstovsek, MD PhD

Blood (2016) 128 (22): 1933.

https://doi.org/10.1182/blood.V128.22.1933.1933

Published: 2016

Journal Articles

Curious Case of Profound Thrombocytopenia in a Pregnant Woman

Prabhsimranjot Singh, MBBS, Makardhwaj S Shrivastava, MBBS, Daniel Benasher, MD, Audrik Perez, MD, Philip Rubin, MD

Blood (2016) 128 (22): 4944.

https://doi.org/10.1182/blood.V128.22.4944.4944

Published: 2016

Journal Articles

Malignancy Risk Markers in a Cohort of Referrals for Lymphadenopathy; An Evaluation of Clinical Features Including Lymph Node Size

Orlando Esparza, MD, Ana Xavier, MD, Matthew A. Kutny, MD, Julie A. Wolfson, MD, Jeffrey D. Lebensburger, DO MSPH

Blood (2016) 128 (22): 2385.

https://doi.org/10.1182/blood.V128.22.2385.2385

Published: 2016

Journal Articles

Complex Karyotype in Mantle Cell Lymphoma (MCL) Is Associated with Inferior Progression-Free Survival in Patients (pts) Receiving R-Hypercvad Followed By Autologous Stem Cell Transplant

Michael Jinpyo Lee, B.S., Jeffrey Switchenko, PhD, Janeen S Thomas, Jean L. Koff, MD, Loretta Nastoupil, MD, Mary Jo Lechowicz, MD, Amelia A Langston, MD, Christopher Flowers, MD, Jonathon B. Cohen, MD

Blood (2015) 126 (23): 5095.

https://doi.org/10.1182/blood.V126.23.5095.5095

Published: 2015

NARROW

Combination of the MEK Inhibitor Trametinib and Pyrvinium Pamoate Efficiently Targets RAS Pathway-Mutated Acute Myeloid Leukemia in Preclinical Models

Results from a Phase 2 Study of Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary Myelofibrosis

Impact of FLT3 -ITD Remission Depth in Acute Myeloid Leukemia Patients Prognosis Prediction before Allogeneic Hematopoietic Cell Transplantation

Incidence of Differentiation Syndrome with Ivosidenib (IVO) and Enasidenib (ENA) for Treatment of Patients with Relapsed or Refractory (R/R) Isocitrate Dehydrogenase (IDH)1- or IDH2-Mutated Acute Myeloid Leukemia (AML): A Systematic Analysis By the U.S. Food and Drug Administration (FDA)

Increased Monocytic Myeloid-Derived Suppressor Cells in the Marrow of Relapsed/Refractory Acute Myeloid Leukemia Patients Following Induction Chemotherapy

Atypical Chronic Myeloid Leukemia

Clinical Benefit of Ropeginterferon Alfa 2b (P1101) in Patients with Myelofibrosis

Increased Disease Burden Among Black Children Compared to White Children with Newly Diagnosed Acute Myeloid Leukemia

Targeting of the Interleukin-7 Receptor Alpha-Chain (IL-7Rα) Blocks B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Development and Reduces Leukemic Infiltration to the Central Nervous System (CNS)

Complex Karyotype Predicts the Prognostics Impact of WBC Count in Untreated Mantle Cell Lymphoma and Is Associated with Shortened Survival Independent of Specific Cytogenetic Abnormalities

Examining the Treatment Patterns and Blood Counts Among Patients with Polycythemia Vera Treated with Hydroxyurea in the United States: An Analysis from the Reveal Study

JAK2 V617F -Mutant Vascular Niche Promotes JAK2 V617F Clonal Expansion in Myeloproliferative Neoplasms

Nuclear NFATc1 Causes Development of Fms-like Receptor Tyrosine Kinase 3 Receptor (FLT3) Internal Tandem Duplication Mutation-Positive (FLT3-ITD) Acute Myeloid Leukemia (AML) and Mediates Drug Resistance

Engraftment and Long-Term Survival at Low Burden of Leukemic Blasts from Primary MRD+ Human Bone Marrow in a Xenotransplant Setting

Mathematical Modeling of White Blood Cell Population Dynamics for Diagnosis and Prognosis

Venous Thromboembolic Events in Diffuse Large B Cell Lymphoma Patients: Risk Factors and Outcomes

Immature Platelet Fraction Is Associated with JAK2 V617F Mutation and Features of Advanced Disease in Myelofibrosis

Curious Case of Profound Thrombocytopenia in a Pregnant Woman

Malignancy Risk Markers in a Cohort of Referrals for Lymphadenopathy; An Evaluation of Clinical Features Including Lymph Node Size

Complex Karyotype in Mantle Cell Lymphoma (MCL) Is Associated with Inferior Progression-Free Survival in Patients (pts) Receiving R-Hypercvad Followed By Autologous Stem Cell Transplant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only